Cargando…
P-030: CRIZANLIZUMAB REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SCD PATIENTS IN STANDARDIZED MICROFLUIDIC PLATFORM: IN VITRO TECHNOLOGY ASSESSMENT
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426784/ http://dx.doi.org/10.1097/01.HS9.0000873016.07993.e1 |
| _version_ | 1784778755479175168 |
|---|---|
| author | C., FEDERICI E., KUCUKAL R., KOCEVAR L., GILKEY S., SERTEL K., MONCHAMP A., WOLFE L., NAYAK A., BRUEDERLE J., ZAK U., GURKAN |
| author_facet | C., FEDERICI E., KUCUKAL R., KOCEVAR L., GILKEY S., SERTEL K., MONCHAMP A., WOLFE L., NAYAK A., BRUEDERLE J., ZAK U., GURKAN |
| author_sort | C., FEDERICI |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9426784 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94267842022-08-31 P-030: CRIZANLIZUMAB REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SCD PATIENTS IN STANDARDIZED MICROFLUIDIC PLATFORM: IN VITRO TECHNOLOGY ASSESSMENT C., FEDERICI E., KUCUKAL R., KOCEVAR L., GILKEY S., SERTEL K., MONCHAMP A., WOLFE L., NAYAK A., BRUEDERLE J., ZAK U., GURKAN Hemasphere Poster Presentations Lippincott Williams & Wilkins 2022-08-16 /pmc/articles/PMC9426784/ http://dx.doi.org/10.1097/01.HS9.0000873016.07993.e1 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Poster Presentations C., FEDERICI E., KUCUKAL R., KOCEVAR L., GILKEY S., SERTEL K., MONCHAMP A., WOLFE L., NAYAK A., BRUEDERLE J., ZAK U., GURKAN P-030: CRIZANLIZUMAB REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SCD PATIENTS IN STANDARDIZED MICROFLUIDIC PLATFORM: IN VITRO TECHNOLOGY ASSESSMENT |
| title | P-030: CRIZANLIZUMAB REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SCD PATIENTS IN STANDARDIZED MICROFLUIDIC PLATFORM: IN VITRO TECHNOLOGY ASSESSMENT |
| title_full | P-030: CRIZANLIZUMAB REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SCD PATIENTS IN STANDARDIZED MICROFLUIDIC PLATFORM: IN VITRO TECHNOLOGY ASSESSMENT |
| title_fullStr | P-030: CRIZANLIZUMAB REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SCD PATIENTS IN STANDARDIZED MICROFLUIDIC PLATFORM: IN VITRO TECHNOLOGY ASSESSMENT |
| title_full_unstemmed | P-030: CRIZANLIZUMAB REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SCD PATIENTS IN STANDARDIZED MICROFLUIDIC PLATFORM: IN VITRO TECHNOLOGY ASSESSMENT |
| title_short | P-030: CRIZANLIZUMAB REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SCD PATIENTS IN STANDARDIZED MICROFLUIDIC PLATFORM: IN VITRO TECHNOLOGY ASSESSMENT |
| title_sort | p-030: crizanlizumab reduces endothelial adhesion of red blood cells from scd patients in standardized microfluidic platform: in vitro technology assessment |
| topic | Poster Presentations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426784/ http://dx.doi.org/10.1097/01.HS9.0000873016.07993.e1 |
| work_keys_str_mv | AT cfederici p030crizanlizumabreducesendothelialadhesionofredbloodcellsfromscdpatientsinstandardizedmicrofluidicplatforminvitrotechnologyassessment AT ekucukal p030crizanlizumabreducesendothelialadhesionofredbloodcellsfromscdpatientsinstandardizedmicrofluidicplatforminvitrotechnologyassessment AT rkocevar p030crizanlizumabreducesendothelialadhesionofredbloodcellsfromscdpatientsinstandardizedmicrofluidicplatforminvitrotechnologyassessment AT lgilkey p030crizanlizumabreducesendothelialadhesionofredbloodcellsfromscdpatientsinstandardizedmicrofluidicplatforminvitrotechnologyassessment AT ssertel p030crizanlizumabreducesendothelialadhesionofredbloodcellsfromscdpatientsinstandardizedmicrofluidicplatforminvitrotechnologyassessment AT kmonchamp p030crizanlizumabreducesendothelialadhesionofredbloodcellsfromscdpatientsinstandardizedmicrofluidicplatforminvitrotechnologyassessment AT awolfe p030crizanlizumabreducesendothelialadhesionofredbloodcellsfromscdpatientsinstandardizedmicrofluidicplatforminvitrotechnologyassessment AT lnayak p030crizanlizumabreducesendothelialadhesionofredbloodcellsfromscdpatientsinstandardizedmicrofluidicplatforminvitrotechnologyassessment AT abruederle p030crizanlizumabreducesendothelialadhesionofredbloodcellsfromscdpatientsinstandardizedmicrofluidicplatforminvitrotechnologyassessment AT jzak p030crizanlizumabreducesendothelialadhesionofredbloodcellsfromscdpatientsinstandardizedmicrofluidicplatforminvitrotechnologyassessment AT ugurkan p030crizanlizumabreducesendothelialadhesionofredbloodcellsfromscdpatientsinstandardizedmicrofluidicplatforminvitrotechnologyassessment |